Hepion Pharmaceuticals HEPA
OTC HEPA
$0.12 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Hepion Pharmaceuticals (HEPA) Liabilities and Shareholders Equity (2013 - 2025)

Updated

Hepion Pharmaceuticals (HEPA) posted Liabilities and Shareholders Equity of $3.07 million for Q4 2025, up 90.2% from $1.61 million a year earlier but down 17.9% from the prior quarter.

Analysis

Hepion Pharmaceuticals (HEPA) Liabilities and Shareholders Equity (2013 - 2025) Analysis & Trends

Since Q4 2017, Hepion Pharmaceuticals has reported Liabilities and Shareholders Equity for 33 quarters.

  • Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -42.5% (FY2020 to FY2025).
  • In prior years, Hepion Pharmaceuticals' Liabilities and Shareholders Equity was $1.61 million in FY2024 (-91.1%), $18.09 million in FY2023 (-70.0%), $60.24 million in FY2022 (-41.8%) and $103.55 million in FY2021 (+112.9%).
  • Quarterly Liabilities and Shareholders Equity has run from a low of $1.61 million in Q4 2024 to a high of $123.76 million in Q1 2021 over five years.
  • On a year-over-year basis, Liabilities and Shareholders Equity increased in two of the last eight quarters, with an average decline of 40.3%.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q3 2021, with growth of 448.0%; the weakest was Q4 2024, with a decline of 91.1%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $3.74 million (Q3 2025), $4.51 million (Q2 2025) and $6.32 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn 109.22 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn 19.35 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn 93.31 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn 45.22 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn 50.73 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn 13.87 Bn
10 Hepion Pharmaceuticals 1.22 Mn -10.45 Mn - 3.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.07 Mn
Sep 30, 2025 3.74 Mn
Jun 30, 2025 4.51 Mn
Mar 31, 2025 6.32 Mn
Dec 31, 2024 1.61 Mn
Sep 30, 2024 3.72 Mn
Jun 30, 2024 6.01 Mn
Mar 31, 2024 15.99 Mn
Dec 31, 2023 18.09 Mn
Sep 30, 2023 25.00 Mn
Jun 30, 2023 36.50 Mn
Mar 31, 2023 49.50 Mn
Dec 31, 2022 60.24 Mn
Sep 30, 2022 69.70 Mn
Jun 30, 2022 83.57 Mn
Mar 31, 2022 95.86 Mn
Dec 31, 2021 103.55 Mn
Sep 30, 2021 111.60 Mn
Jun 30, 2021 119.75 Mn
Mar 31, 2021 123.76 Mn
API Access

Hepion Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=HEPA&period=max&api_key=YOUR_API_KEY